Breaking News

Anavex Appoints Clinical Ops VP

August 7, 2014

Wyeth veteran to head clinical programs

Tasos Zografidis, Ph.D. has been appointed vice president of Clinical Operations at Anavex Life Sciences Corp. In this newly created position, Dr. Zografidis will be responsible for managing Anavex's clinical programs, including the upcoming Phase IIa trial for ANAVEX 2-73 and ANAVEX PLUS, the company's lead drug candidate combination for Alzheimer's disease.
Dr. Zografidis has more than 25 years of experience in the pharma and healthcare industry, having spent 12 years at Wyeth in clinical project management and most recently served as a clinical and pharmaceutical consultant. At Wyeth, Dr. Zografidis spearheaded population pharmacokinetics analysis and its implementation in the clinical setting and positively differentiated compounds. Dr. Zografidis first joined Wyeth in 1998 as a product manager.  
"Dr. Zografidis is a tremendous addition to our management team and I am very pleased to welcome him to Anavex," said Christopher U. Missling, Ph.D., president and chief executive officer of Anavex.
blog comments powered by Disqus
  • CRO-Sponsor Partnerships

    CRO-Sponsor Partnerships

    Craig Morgan, Brand Development Director, goBalto Inc.||October 11, 2016
    10 tips for enabling better CRO and sponsor collaborations

  • The Human Parts of Mouse Models

    The Human Parts of Mouse Models

    Julia Schueler, Head of in vivo Operations, Oncotest, a Charles River company ||October 11, 2016
    The PDX model system has come back into focus

  • The Search &  Rescue Mission for Data Integrity

    The Search & Rescue Mission for Data Integrity

    Mike Jovanis, Vice President of Vault QualityDocs, Veeva Systems||October 11, 2016
    Cloud technology is essential for success